Collplant Biotechnologies Debt 2024

Collplant Biotechnologies Aktienanalyse

What does Collplant Biotechnologies do?

CollPlant Biotechnologies Ltd is a biotechnology company specializing in the development and production of collagen-based products. The company was founded in 2004 and is headquartered in Rehovot, Israel. The company's history is rooted in collagen research. Collagen is an important component of connective tissue, providing structure and strength. The company specializes in the use of plant-based collagen derived from a specific plant called Nicotiana tabacum. Plant-based collagen has the advantage of being biocompatible, biodegradable, and more cost-effective than animal-based collagen. CollPlant Biotechnologies' business model is to develop and sell collagen-based products for various industries. The company's main sectors are medicine, cosmetics, and 3D printing. Each sector offers its own products and has different requirements for collagen. In the medicine sector, CollPlant Biotechnologies offers collagen-based products for wound healing, bone regeneration, and treatment of skin diseases. The advantage of plant-based collagen is that it causes very few allergic reactions and is well tolerated. In the cosmetics sector, the company develops collagen-based products for skincare, particularly for reducing wrinkles and fine lines. CollPlant Biotechnologies also has its own cosmetics brand called "Verifeel," which offers collagen-based creams and serums. The 3D printing sector is a relatively new initiative for the company. Here, CollPlant Biotechnologies develops collagen-based materials that can be used for 3D printing of biological tissues and organs. The advantage of plant-based collagen in 3D printing is that it is highly moldable and biocompatible. CollPlant Biotechnologies also has a partnership with one of the world's largest tobacco companies, Philip Morris International. Together, they are working to produce plant-based collagen on an industrial scale. Overall, CollPlant Biotechnologies has a promising future. The company has specialized in a unique niche in the biotechnology sector and offers a variety of products for different industries. With the partnership with Philip Morris International and the development of 3D printing materials, the company also has other exciting opportunities for the future. Collplant Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Collplant Biotechnologies's Debt Structure

Collplant Biotechnologies's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Collplant Biotechnologies's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Collplant Biotechnologies’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Collplant Biotechnologies’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Collplant Biotechnologies Stock

What is the debt of Collplant Biotechnologies this year?

Collplant Biotechnologies has a debt level of -26.67 USD this year.

What was the debt of Collplant Biotechnologies compared to the previous year?

The debt of Collplant Biotechnologies has increased by -10.04% compared to the previous year dropped.

What are the consequences of high debt for investors in Collplant Biotechnologies?

High debt can pose a risk for investors of Collplant Biotechnologies, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Collplant Biotechnologies?

Low debt means that Collplant Biotechnologies has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Collplant Biotechnologies affect the company?

An increase in debt of Collplant Biotechnologies can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Collplant Biotechnologies affect the company?

A reduction in debt of Collplant Biotechnologies can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Collplant Biotechnologies?

Some factors that can influence the debt of Collplant Biotechnologies include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Collplant Biotechnologies so important for investors?

The debts of Collplant Biotechnologies are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Collplant Biotechnologies take to change the debt?

To change the debt, Collplant Biotechnologies can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Collplant Biotechnologies pay?

Over the past 12 months, Collplant Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Collplant Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Collplant Biotechnologies?

The current dividend yield of Collplant Biotechnologies is .

When does Collplant Biotechnologies pay dividends?

Collplant Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Collplant Biotechnologies?

Collplant Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Collplant Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Collplant Biotechnologies located?

Collplant Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Collplant Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Collplant Biotechnologies from 6/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Collplant Biotechnologies pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of Collplant Biotechnologies in the year 2023?

In the year 2023, Collplant Biotechnologies distributed 0 USD as dividends.

In which currency does Collplant Biotechnologies pay out the dividend?

The dividends of Collplant Biotechnologies are distributed in USD.